225 related articles for article (PubMed ID: 2944915)
1. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.
Tausk FA; McCutchan A; Spechko P; Schreiber RD; Gigli I
J Clin Invest; 1986 Oct; 78(4):977-82. PubMed ID: 2944915
[TBL] [Abstract][Full Text] [Related]
2. Hematologic correlates and the role of erythrocyte CR1 (C3b receptor) in the development of AIDS.
Inada Y; Lange M; McKinley GF; Sonnabend JA; Fonville TW; Kanemitsu T; Tanaka M; Clark WS
AIDS Res; 1986; 2(3):235-47. PubMed ID: 2944517
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection.
Jouvin MH; Rozenbaum W; Russo R; Kazatchkine MD
AIDS; 1987 Jul; 1(2):89-94. PubMed ID: 2966632
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
5. Precipitable immune complexes in healthy homosexual men, acquired immune deficiency syndrome and the related lymphadenopathy syndrome.
Euler HH; Kern P; Löffler H; Dietrich M
Clin Exp Immunol; 1985 Feb; 59(2):267-75. PubMed ID: 3156700
[TBL] [Abstract][Full Text] [Related]
6. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of erythrocyte C3b receptor (CR1) in AIDS and AIDS-related syndromes.
Tausk FA; McCutchan JA; Schreiber RD; Spechko P; Gigli I
Biosci Rep; 1986 Jan; 6(1):81-6. PubMed ID: 2938642
[TBL] [Abstract][Full Text] [Related]
8. The human C3b receptor: function and role in human diseases.
Tausk F; Gigli I
J Invest Dermatol; 1990 Jun; 94(6 Suppl):141S-145S. PubMed ID: 2141047
[TBL] [Abstract][Full Text] [Related]
9. Deficiency in C3b receptors on neutrophils of patients with chronic granulomatous disease and hyperimmunoglobulin-E recurrent infection (Job's) syndrome.
Gaither TA; Gallin JI; Iida K; Nussenzweig V; Frank MM
Inflammation; 1984 Dec; 8(4):429-44. PubMed ID: 6240460
[TBL] [Abstract][Full Text] [Related]
10. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte complement C3b receptor (CR1) levels and immune complex-induced manifestations in patients with primary Sjögren's syndrome.
Thomsen BS; Oxholm P; Nielsen H; Manthorpe R
Scand J Rheumatol Suppl; 1986; 61():127-30. PubMed ID: 2954207
[TBL] [Abstract][Full Text] [Related]
13. The detection of circulating immune complexes containing C1q and IgG using a new rapid serum ELISA test system.
Reckel RP; Harris J; Botsko E; Wellerson R; Varga S
Diagn Immunol; 1984; 2(4):228-37. PubMed ID: 6335421
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies and circulating immune complexes in subjects infected with human immunodeficiency virus.
Mayer-Siuta R; Keil LB; DeBari VA
Med Microbiol Immunol; 1988; 177(4):189-94. PubMed ID: 3047537
[TBL] [Abstract][Full Text] [Related]
15. Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
Jepsen HH; Teisner B; Rasmussen JM; Svehag SE
Scand J Immunol; 1989 Feb; 29(2):247-55. PubMed ID: 2522236
[TBL] [Abstract][Full Text] [Related]
16. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
[TBL] [Abstract][Full Text] [Related]
17. Complement C3b receptors on erythrocytes, circulating immune complexes, and complement C3 split products in patients with primary Sjögren's syndrome.
Thomsen BS; Oxholm P; Manthorpe R; Nielsen H
Arthritis Rheum; 1986 Jul; 29(7):857-62. PubMed ID: 2943291
[TBL] [Abstract][Full Text] [Related]
18. Humoral immune responses in healthy heterosexual, homosexual and vasectomized men and in homosexual men with the acquired immune deficiency syndrome.
Witkin SS; Bongiovanni AM; Yu IR; Goldstein M; Wallace J; Sonnabend J
AIDS Res; 1983-1984; 1(1):31-44. PubMed ID: 6546003
[TBL] [Abstract][Full Text] [Related]
19. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
[TBL] [Abstract][Full Text] [Related]
20. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
